A detailed history of Hbk Sorce Advisory LLC transactions in Elevance Health, Inc. stock. As of the latest transaction made, Hbk Sorce Advisory LLC holds 755 shares of ELV stock, worth $303,925. This represents 0.02% of its overall portfolio holdings.

Number of Shares
755
Previous 734 2.86%
Holding current value
$303,925
Previous $397,000 1.26%
% of portfolio
0.02%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$500.12 - $562.29 $10,502 - $11,808
21 Added 2.86%
755 $392,000
Q2 2024

Aug 08, 2024

BUY
$497.49 - $547.8 $8,954 - $9,860
18 Added 2.51%
734 $397,000
Q1 2024

May 09, 2024

SELL
$464.61 - $519.96 $25,553 - $28,597
-55 Reduced 7.13%
716 $371,000
Q4 2023

Jan 25, 2024

BUY
$433.51 - $488.06 $6,069 - $6,832
14 Added 1.85%
771 $363,000
Q3 2023

Nov 06, 2023

BUY
$414.13 - $475.93 $1,656 - $1,903
4 Added 0.53%
757 $329,000
Q2 2023

Aug 04, 2023

SELL
$436.33 - $496.2 $482,144 - $548,301
-1,105 Reduced 59.47%
753 $334,000
Q1 2023

Aug 15, 2023

BUY
$446.3 - $502.2 $3,124 - $3,515
7 Added 0.93%
760 $349,000
Q1 2023

May 15, 2023

BUY
$446.3 - $502.2 $829,225 - $933,087
1,858 New
1,858 $1.28 Million
Q2 2022

Aug 15, 2022

BUY
$444.32 - $529.84 $39,544 - $47,155
89 Added 9.06%
1,071 $517,000
Q1 2022

May 13, 2022

SELL
$428.44 - $502.48 $37,702 - $44,218
-88 Reduced 8.22%
982 $482,000
Q3 2021

Nov 15, 2021

SELL
$357.51 - $398.13 $4,647 - $5,175
-13 Reduced 1.2%
1,070 $399,000
Q2 2021

Aug 12, 2021

SELL
$352.19 - $401.9 $3,521 - $4,019
-10 Reduced 0.91%
1,083 $413,000
Q1 2021

May 14, 2021

BUY
$287.7 - $371.31 $35,099 - $45,299
122 Added 12.56%
1,093 $392,000
Q4 2020

Feb 12, 2021

BUY
$270.17 - $333.15 $4,592 - $5,663
17 Added 1.78%
971 $312,000
Q3 2020

Nov 13, 2020

SELL
$245.73 - $284.63 $9,337 - $10,815
-38 Reduced 3.83%
954 $256,000
Q1 2020

May 15, 2020

SELL
$174.68 - $307.74 $2,096 - $3,692
-12 Reduced 1.2%
992 $225,000
Q3 2019

Nov 14, 2019

SELL
$237.69 - $310.48 $133,581 - $174,489
-562 Reduced 35.89%
1,004 $241,000
Q2 2019

Aug 15, 2019

BUY
$236.25 - $293.76 $369,967 - $460,028
1,566 New
1,566 $442,000
Q2 2019

Aug 14, 2019

SELL
$236.25 - $293.76 $366,896 - $456,209
-1,553 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$248.42 - $317.42 $45,460 - $58,087
183 Added 13.36%
1,553 $446,000
Q4 2018

Feb 14, 2019

SELL
$249.0 - $296.25 $15,936 - $18,960
-64 Reduced 4.46%
1,370 $360,000
Q2 2018

Aug 10, 2018

BUY
$220.13 - $245.16 $41,384 - $46,090
188 Added 15.09%
1,434 $0
Q1 2018

May 15, 2018

SELL
$215.63 - $258.19 $6,900 - $8,262
-32 Reduced 2.5%
1,246 $274,000
Q4 2017

Feb 15, 2018

BUY
$183.76 - $234.96 $13,965 - $17,856
76 Added 6.32%
1,278 $288,000
Q3 2017

Nov 14, 2017

BUY
$181.44 - $197.43 $218,090 - $237,310
1,202
1,202 $228,000

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $96.6B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Hbk Sorce Advisory LLC Portfolio

Follow Hbk Sorce Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Sorce Advisory LLC with notifications on news.